Literature DB >> 25777486

Vascular graft infections and role of PET/CT in patients with persistent bacteraemia.

Lokesh Shahani1.   

Abstract

Prosthetic vascular graft infection although a rare complication of vascular reconstruction surgery; has been associated with significant morbidity and mortality. The author presents two patients with prosthetic aortic graft presenting as fever and methicillin sensitive Staphylococcus aureus bacteraemia without any other localising sign of infection. Both patients had a history of postoperative wound infection after their graft placement. Patients remained persistently bacteraemic on appropriate antimicrobial therapy making the clinician suspicious of a vascular graft infection. A [18 F] fluoro-2-deoxy-d glucose positron emission tomography associated to CT scan was used to identify the prosthetic vascular graft infection and since both patients were high-risk surgical candidates, a conservative medical approach was used. They were treated with 6 weeks of nafcillin and rifampin, followed by long-term doxycycline for suppression. This highlights the importance of considering vascular graft infection in patients with recurrent and persistent bacteraemia despite adequate therapy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25777486      PMCID: PMC4369020          DOI: 10.1136/bcr-2014-207678

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Prosthetic patch remnants to treat infected arterial grafts.

Authors:  K D Calligaro; F J Veith; J A Valladares; J McKay; N Schindler; M J Dougherty
Journal:  J Vasc Surg       Date:  2000-02       Impact factor: 4.268

2.  Aortic graft infection: evolution in management.

Authors:  Linda Reilly
Journal:  Cardiovasc Surg       Date:  2002-08

Review 3.  Current role of imaging in diagnosing aortic graft infections.

Authors:  Janneke L M Bruggink; Riemer H J A Slart; Jillis A Pol; Michel M P J Reijnen; Clark J Zeebregts
Journal:  Semin Vasc Surg       Date:  2011-12       Impact factor: 1.000

4.  Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses.

Authors:  M Spacek; O Belohlavek; J Votrubova; P Sebesta; P Stadler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-24       Impact factor: 9.236

5.  Treatment of deep infection following thoracic aorta graft replacement without graft removal.

Authors:  T Kaneda; J Iemura; H Oka; T Inoue; Z W Zhang; T Matsumoto; M Onoe; M Otaki; H Oku; N Ishigami; M Aoshima
Journal:  Ann Vasc Surg       Date:  2001-07       Impact factor: 1.466

Review 6.  New alternatives in management of the infected vascular prosthesis.

Authors:  S E Wilson
Journal:  Surg Infect (Larchmt)       Date:  2001       Impact factor: 2.150

Review 7.  Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment.

Authors:  R Chiesa; D Astore; S Frigerio; L Garriboli; G Piccolo; R Castellano; M Scalamogna; A Odero; S Pirrelli; G Biasi; P Mingazzini; P Biglioli; G Polvani; A Guarino; G Agrifoglio; A Tori; G Spina
Journal:  Acta Chir Belg       Date:  2002-08       Impact factor: 1.090

8.  Are gram-negative bacteria a contraindication to selective preservation of infected prosthetic arterial grafts?

Authors:  K D Calligaro; F J Veith; M L Schwartz; R P Savarese; D A DeLaurentis
Journal:  J Vasc Surg       Date:  1992-09       Impact factor: 4.268

9.  Endovascular treatment of infected aortic aneurysms.

Authors:  P Sedivy; M Spacek; K El Samman; O Belohlavek; T Mach; V Jindrak; V Rohn; P Stadler
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-08-20       Impact factor: 7.069

Review 10.  Management of infected aortic grafts.

Authors:  P F Lawrence
Journal:  Surg Clin North Am       Date:  1995-08       Impact factor: 2.741

View more
  1 in total

Review 1.  Treatment of Aortic Graft Infection in the Endovascular Era.

Authors:  Rebecca Sorber; Michael J Osgood; Christopher J Abularrage; James H Black; Ying Wei Lum
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.